Department of Biostatistics and Epidemiology
Bayesian nonparametric methods; variable selection and clustering in high-dimensional data; statistical analyses in genomics and proteomics data; and clinical trial design and analysis.
Dr. Kim is an assistant professor of Biostatistics at RSPH, and also a biostatistician in Biometrics division of Rutgers Cancer Institute of New Jersey. She received her MS and PhD degrees in statistics at Texas A&M University.
Dr. Kim’s research areas of interest include Bayesian non-parametric methods, variable selection and clustering in high-dimensional data, statistical analyses in genomic and proteomic data, and clinical trial design and analyses. As a biostatistician of Biometrics division at RCINJ, Dr. Kim has been actively collaborating with the PIs in the development of Phase I – III clinical trials.
I Faiena,S Kim,N Farber,YS Kwon,B Shinder,N Patel,AH Salmasi,T Jang,EA Singer,WJ Kim,IY Kim (2017) "Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers.", Oncotarget 8(5) 109783-109790 http://www.ncbi.nlm.nih.gov/pubmed/?term=29312648&report=abstract
CS Han,S Kim,KD Radadia,PT Zhao,SE Elsamra,EO Olweny,RE Weiss (2017) "Comparison of Urinary Tract Infection Rates Associated with Transurethral Catheterization, Suprapubic Tube and Clean Intermittent Catheterization in the Postoperative Setting: A Network Meta-Analysis.", The Journal of Urology 198(5) 1353-1358 http://www.ncbi.nlm.nih.gov/pubmed/?term=28736320&report=abstract
N Yegya-Raman,S Kim,MP Deek,D Li,A Gupta,L Bond,A Dwivedi,JK Braver,M Reyhan,A Mittal,B Gui,J Malhotra,J Aisner,SK Jabbour (2018) "Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung Cancer.", International Journal of Radiation Oncology, Biology, Physics 101(5) 1104-1112 http://www.ncbi.nlm.nih.gov/pubmed/?term=29730063&report=abstract
MP Deek,S Kim,R Beck,N Yegya-Raman,J Langenfeld,J Malhotra,O Mahmoud,J Aisner,SK Jabbour (2018) "Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non-Small Cell Lung Cancer Are Associated With Decreases in Overall Survival.", Clinical Lung Cancer 19(5) e381-e390 http://www.ncbi.nlm.nih.gov/pubmed/?term=29752011&report=abstract